1987
DOI: 10.1016/0278-2391(87)90271-0
| |Summarize |Cite
|
Sign up to set email alerts

Diagnosis and treatment of von Willebrand's disease

Search citation statements

Order By: Relevance

Paper Sections

Select...
7
0
0
0

Citation Types

0
2
0
0

Year Published

Range
1992
1992
2021
2021

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

Cited by 7 publications

(2 citation statements)

References 12 publications

0
2
0
0
Order By: Relevance
How the paper below cites the one you are viewing
“…vWD is often classified into four basic types based on the separation of vWF multimers or subunits of varying molecular weights by electrophoresis. 55 Type I accounts for approximately 85% of occurrences, with all multimeric forms present in reduced concentrations. Type II is characterized by an absence of high-molecular-weight multimers and occurs in 10 to 15% of vWD patients.…”
Section: Factors XIII and I Deficiencies
mentioning
confidence: 99%
“…Intermediate-purity F VIII concentrates, FFP, and cryoprecipitate are held in reserve for DDAVP nonresponders. 55 Types II and III require intermediate-purity F VIII concentrates, such as Humate-P or Koate-HS, or, rarely, cryoprecipitate or FFP. Bleeding episodes in patients with platelettype vWD are usually controlled with platelet concentrate infusions.…”
Section: Von Willebrand's Disease
mentioning
confidence: 99%
See 1 more Smart Citation